Details of Disease

General Information of Disease (ID: DISMOUMI)

• Disease Name: Granuloma annulare
• Synonyms: granuloma annulare; Granulome annulare
• Definition: Granuloma annulare is a long-term (chronic) skin disease consisting of a rash with reddish bumps arranged in a circle or ring. The most commonly affected areas are the forearms, hands and feet. The lesions associated with granuloma annulare usually resolve without treatment. Strong steroids (applied as a cream or injection) are sometimes used to clear the rash more quickly. Most symptoms will disappear within 2 years (even without treatment), but recurrence is common. The underlying cause of granuloma annulare is unknown.
• Disease Hierarchy:
  DISY5SZC: Dermatitis
  DISMOUMI: Granuloma annulare
• Disease Identifiers:
  MONDO ID: MONDO_0006554
  MESH ID: D016460
  UMLS CUI: C0085074
  MedGen ID: 88319
  SNOMED CT ID: 65508009

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 23 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Alclometasone	DMAE84F	Approved	Small molecular drug	[1]
Amcinonide	DMM1JL9	Approved	Small molecular drug	[2]
Ammonium lactate	DMXMHBB	Approved	Small molecular drug	[3]
Benzoyl peroxide	DMSTW1Q	Approved	Small molecular drug	[4]
Betamethasone	DMAHJEF	Approved	Small molecular drug	[5]
Clocortolone	DM9ZMQH	Approved	Small molecular drug	[6]
Cortisone Acetate	DMG8K57	Approved	Small molecular drug	[7]
Desonide	DMTP2NJ	Approved	Small molecular drug	[8]
Desoximetasone	DM4PXF6	Approved	Small molecular drug	[9]
Dexamethasone	DMMWZET	Approved	Small molecular drug	[10]
Diflorasone	DMI9PRJ	Approved	Small molecular drug	[11]
Flumethasone	DMUNG4A	Approved	NA	[12]
Fluocinolone Acetonide	DMG2KI4	Approved	Small molecular drug	[13]
Fluocinonide	DM65KL8	Approved	Small molecular drug	[14]
Flurandrenolide	DMHCI9S	Approved	Small molecular drug	[15]
Fluticasone propionate	DMRWLB2	Approved	NA	[16]
Halcinonide	DMGLAX1	Approved	Small molecular drug	[17]
Hydrocortisone	DMGEMB7	Approved	Small molecular drug	[18]
Methylprednisolone	DM4BDON	Approved	Small molecular drug	[19]
Mometasone	DM45OJN	Approved	Small molecular drug	[20]
Prednicarbate	DMBUNVW	Approved	Small molecular drug	[21]
Prednisolone	DMQ8FR2	Approved	Small molecular drug	[22]
Triamcinolone	DM98IXF	Approved	Small molecular drug	[23]

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
IDP-122	DM3A701	Phase 3	NA	[24]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Alclometasone FDA Label
• [2] Amcinonide FDA Label
• [3] Ammonium lactate FDA Label
• [4] Benzoyl peroxide FDA Label
• [5] Betamethasone FDA Label
• [6] Clocortolone FDA Label
• [7] Cortisone acetate FDA Label
• [8] Desonide FDA Label
• [9] Desoximetasone FDA Label
• [10] Dexamethasone FDA Label
• [11] Diflorasone FDA Label
• [12] Flumethasone FDA Label
• [13] Fluocinolone acetonide FDA Label
• [14] Fluocinonide FDA Label
• [15] Flurandrenolide FDA Label
• [16] Fluticasone propionate FDA Label
• [17] Halcinonide FDA Label
• [18] Hydrocortisone FDA Label
• [19] Methylprednisolone FDA Label
• [20] Mometasone FDA Label
• [21] Prednicarbate FDA Label
• [22] Prednisolone FDA Label
• [23] Triamcinolone FDA Label
• [24] A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.